Actualización en dispepsia no ulcerosa

1. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G. Evaluation of dyspepsia. Gastroenterology 1998;114:582-595.
2. Agréus L, Talley N. Challenges in managing dyspepsia. BMJ 1997;315:1284-1288.
3. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht consensus report. Gut 1997;41:8-13.
4. Jones RH, Baxter G. Lansoprazole 30mg daily versus ranitidine 150mg bd in the treatment in acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997;11:541-546.
5. Velduhyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Report of an International Working Party. Am J Gastroenterol 1996;91:660-673.
6. Locke GR, Talley NJ, Fett S, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux in the community. Gastroenterology 1997;112:1448-1456
7. Agréus L,Svärdsudd K, Nyrén O, Tibblin G. Irritable b